"2025 ESC/EAS Dyslipidaemia フォーカスアップデート:臨床的解釈と実用的な影響"
Luca Bonanni1,2, Ada Cutolo3,4, Nicola Ferri5
1Department of Medicine, Ospedale dell'Angelo, Venice, Italy. luca.bonanni@aulss3.veneto.it.
Cardiovascular drugs and therapy
|February 18, 2026
まとめ
2025 ESC/EAS Dyslipidaemia フォーカスアップデートでは,より迅速な治療の強化と,心血管疾患のリスクを減らすための新しい治療法を強調して,脂質低下戦略を精製しています. パーソナライズされた,持続的な低密度リポプロテインコレステロール (LDL-C) の管理を促進し,より良い結果をもたらします.
科学分野:
- 心臓病学 心臓病学
- リピドロジーは,脂質学です.
- 予防医学は,予防的な医療です.
背景:
- 2019年のEuropean Society of Cardiology/European Atherosclerosis Society (ESC/EAS) のガイドラインは,失血症の管理のための枠組みを提供している.
- 新興のエビデンスは,新しい発見を組み込み,臨床実践を洗練するために,焦点を合わせた更新を必要とします.
研究 の 目的:
- 2019年ESC/EASの脱脂症に関するガイドラインを,最新の証拠に基づいて改訂し,更新する.
- 次の包括的なガイドラインの改訂前に,脂質低下療法を最適化するための実行可能な勧告を提供すること.
主な方法:
- 新しい臨床試験データと実世界の証拠を統合する.
- SCORE2/SCORE2-OP,リポタンパク質 (a) [Lp (a) ],冠動脈カルシウム (CAC) スコアリングを含むリスク分層化ツールの再評価.
- 新種の脂質低下剤と治療強化戦略の評価.
主要な成果:
- 低密度リポプロテインコレステロール (LDL-C) の治療目標は一貫しています.
- 治療の強化を加速し,併用療法の使用を拡大することを強調する.
- ベンペド酸,インクリシラン,エヴィナキュマブを特定患者グループで支持する新しい証拠の紹介.
- 急性冠動脈症候群 (ACS) の環境における積極的,早期の強化戦略の強化.
結論:
- この更新は,LDL-C管理のための運用枠組みを強化します.
- 累積的な動脈硬化曝露を最小限に抑えるために,早期に,個別化され,持続的な脂質低下を促進します.
- ディスリピデミアの管理,特にリスクの高い個人およびスタチン不耐性のある人のための洗練されたガイドラインを提供します.
関連する概念動画
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
01:26Atherosclerosis III: Management
465
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
656
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
656
01:26Angina IV: Management
330
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
330
01:27Peripheral Artery Disease III: Interprofessional Care
385
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
385
01:26Coronary Artery Disease IV: Preventive Measures
741
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741